NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Casa Colina Hospital and Centers for Healthcare
Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Stroke (CVA) or TIA, Stroke, Acute, Traumatic Brain Injury
Interventions: Use of Rare Beauty makeup products
Countries: United States
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.
Sex: ALL
Age: 18 Years to 55 Years
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: Individuals aged 18 years to 55 years. * Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments. * Regular users beauty products. * Able to understand and communicate in the language of the study. Exclusion Criteria: * Individuals below 18 years of age or over the age of 55. * Individuals without upper extremity deficits or with severe upper extremity deficits that may affect the participant's ability to engage in study activities. * Participants who are not regular users of beauty products. * Inability to understand and communicate in the language of the study. * Any medical or psychological condition that may affect the participant's ability to provide informed consent or engage in the study activities safely. * Individuals who experience facial skin or eye irritation reported by subject or observed by evaluator at baseline visit * History of allergic reactions, and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc. * Immunocompromised subjects * Individuals who may experience changes in hormones, such as just those using oral contraception for less than three months before the screening visit or who have changed hormonal contraceptive methods within the three months before the Baseline visit or planning to modify hormonal contraception treatment within the duration of the study. * Known to be pregnant, lactating or planning to become pregnant within six months. Subjects who become pregnant during the study must inform the Principal Investigator immediately.
- Pomona, California, United States